Literature DB >> 29553501

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells.

Polina Zjablovskaja1, Petr Danek2, Miroslava Kardosova2, Meritxell Alberich-Jorda3.   

Abstract

Understanding of the hematopoietic stem and progenitor cell biology has important implications for regenerative medicine and the treatment of hematological pathologies. Despite the most relevant data that can be acquired using in vivo models or primary cultures, the low abundance of hematopoietic stem and progenitor cells considerably restricts the pool of suitable techniques for their investigation. Therefore, the use of cell lines allows sufficient production of biological material for the performance of screenings or assays that require large cell numbers. Here we present a detailed description, readout, and interpretation of proliferation and differentiation assays which are used for the investigation of processes involved in myelopoiesis and neutrophilic differentiation. These experiments employ the 32D/G-CSF-R cytokine dependent murine myeloid cell line, which possesses the ability to proliferate in the presence of IL-3 and differentiate in G-CSF. We provide optimized protocols for handling 32D/G-CSF-R cells and discuss major pitfalls and drawbacks that might compromise the described assays and expected results. Additionally, this article contains protocols for lentiviral and retroviral production, titration, and transduction of 32D/G-CSF-R cells. We demonstrate that genetic manipulation of these cells can be employed to successfully perform functional and molecular studies, which can complement results obtained with primary hematopoietic stem and progenitor cells or in vivo models.

Entities:  

Mesh:

Year:  2018        PMID: 29553501      PMCID: PMC5931329          DOI: 10.3791/57033

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  49 in total

1.  On chromosomal instability: what is the karyotype of your 32D CI3 cell line.

Authors:  A M Aglianó; C Santangelo; I Silvestri; P Gazzaniga; L Giuliani; G Naso; L Frati; R Castiglia
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

2.  PSTPIP2, a Protein Associated with Autoinflammatory Disease, Interacts with Inhibitory Enzymes SHIP1 and Csk.

Authors:  Ales Drobek; Jarmila Kralova; Tereza Skopcova; Marketa Kucova; Petr Novák; Pavla Angelisová; Pavel Otahal; Meritxell Alberich-Jorda; Tomas Brdicka
Journal:  J Immunol       Date:  2015-08-24       Impact factor: 5.422

3.  Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.

Authors:  Saman Abbas; Mathijs A Sanders; Annelieke Zeilemaker; Wendy M C Geertsma-Kleinekoort; Jasper E Koenders; Francois G Kavelaars; Zabiollah G Abbas; Souad Mahamoud; Isabel W T Chu; Remco Hoogenboezem; Justine K Peeters; Ellen van Drunen; Janneke van Galen; H Berna Beverloo; Bob Löwenberg; Peter J M Valk
Journal:  Haematologica       Date:  2014-01-17       Impact factor: 9.941

Review 4.  Tumor suppressor genes in normal and malignant hematopoiesis.

Authors:  Utz Krug; Arnold Ganser; H Phillip Koeffler
Journal:  Oncogene       Date:  2002-05-13       Impact factor: 9.867

5.  Somatostatin modulates G-CSF-induced but not interleukin-3-induced proliferative responses in myeloid 32D cells via activation of somatostatin receptor subtype 2.

Authors:  S P Oomen; A C Ward; L J Hofland; S W Lamberts; B Löwenberg; I P Touw
Journal:  Hematol J       Date:  2001

6.  RGS2 is an important target gene of Flt3-ITD mutations in AML and functions in myeloid differentiation and leukemic transformation.

Authors:  Joachim Schwäble; Chunaram Choudhary; Christian Thiede; Lara Tickenbrock; Bülent Sargin; Claudia Steur; Maike Rehage; Annika Rudat; Christian Brandts; Wolfgang E Berdel; Carsten Müller-Tidow; Hubert Serve
Journal:  Blood       Date:  2004-11-09       Impact factor: 22.113

7.  Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.

Authors:  K R Calvo; D B Sykes; M Pasillas; M P Kamps
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

8.  Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.

Authors:  F Dong; R K Brynes; N Tidow; K Welte; B Löwenberg; I P Touw
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

Review 9.  Colony-stimulating factors for febrile neutropenia during cancer therapy.

Authors:  Charles L Bennett; Benjamin Djulbegovic; LeAnn B Norris; James O Armitage
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245

10.  Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line.

Authors:  M Valtieri; D J Tweardy; D Caracciolo; K Johnson; F Mavilio; S Altmann; D Santoli; G Rovera
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.